News Roswell Park Earns ‘Exceptional’ Rating from National Cancer Institute With Best-Ever Core Grant
News Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers Leads to Clinical Study in Refractory GI Cancers
News Pathways Study Genotype Data, Alliance A011502 Secondary Analysis Headline Roswell Park ASCO24 Presentations
News Phase 2/3 Clinical Trial for Advanced/Metastatic/Unresectable Biliary Tract Cancer Builds on Promising Results of Earlier Study
News Can Irinotecan Boost Complete Response Rate and Long-term Organ Preservation in Rectal Cancer Patients?
News Roswell Park Team Proposes Strategy for Making Pancreatic Tumors Respond to Checkpoint Inhibition
BROADCASTMED